Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Datafoundry AI empowers life sciences, pharma, cosmetics, and medical devices with RWE insights and automation for smarter decisions. Learn more today.
News
The $16 Billion Signal the Pharmaceutical Industry Can No Longer Ignore
By Vivek Kalagara, Founder, Datafoundry.ai The pharmacovigilance outsourcing market is projected to grow from $8.3B to $16.3B. Many see that as a market statistic. But I see it as a warning signal. Because markets don't double without a structural reason.
Read more
Report
Good Pharmacovigilance Practice (GVP): A Strategic Compliance and Global Safety Guide
Good Pharmacovigilance Practices (GVP) are the cornerstone of the European Union's regulatory approach to medicinal product safety. Developed by the European Medicines Agency (EMA), GVP provides a structured framework for how pharmaceutical companies, Mar
Read more
Report
Beneath the Surface of Beauty: The Rising Demand for Advanced Cosmetic Safety Monitoring
The global beauty and personal care industry is evolving rapidly, blending wellness, self-expression, and innovation into products used by billions every day. With the global cosmetics market exceeding $570 billion and U.S. consumer spending approaching $
Read more
Report
Automated Case Intake in Pharmacovigilance: How AI Is Replacing Manual ICSR Workflows
In an era when drug safety decisions must be made in real time, automated case intake is essential as manual processing of Individual Case Safety Reports (ICSRs) has become a costly bottleneck. With rising adverse event volumes, unstructured data sources,
Read more
Report
Audit Readiness in Pharmacovigilance: Traceability, Inspection Prep & Compliance
Meeting the expectations of global regulatory bodies such as the EMA, MHRA, and FDA, and others require every organization to be engaged in pharmacovigilance and safety vigilance to cultivate a continuous audit readiness mindset. To satisfy the demands th
Read more
Report
Pro access
Upgrade to see all 14 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.